Kolexia
Labourey Jean-Luc Oncologie hémato.
Labourey Jean-Luc
Oncologie hémato.
Centre Hospitalier de Carcassonne
Carcassonne, France
77 Activités
233 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Anémie Adénocarcinome Tumeurs colorectales Tumeurs du poumon Carcinome pulmonaire non à petites cellules Récidive tumorale locale Tumeurs du sein Invasion tumorale

Collaborateurs

Voir plus
Hacene Samir
Hacene Samir
Centre Hospitalier de Carcassonne, Carcassonne, France
Boulanger Vincent
Boulanger Vincent
Centre Hospitalier de Carcassonne, Carcassonne, France
Mourey Loic
Mourey Loic
Oncopole Toulouse, Toulouse, France
Theodore Christine
Theodore Christine
Hôpital Foch, Suresnes, France

Industries

Voir plus
A+A
78 collaboration(s)
Dernière en 2023
IQVIA
36 collaboration(s)
Dernière en 2023
Zeste Research
28 collaboration(s)
Dernière en 2022
AstraZeneca
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ORHEO: Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study
Essai Clinique (Pfizer)   26 février 2024
TASKIN: Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
Essai Clinique (Centre Georges-François Leclerc)   12 février 2024
Étude GFPC OBSERVE IIIA-B : analyse prospective des pratiques thérapeutiques françaises dans les cancers bronchiques non à petites cellules de stade III N2
28e Congrès de Pneumologie de Langue Française   01 janvier 2024
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
Clinical genitourinary cancer   07 mai 2023
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse: Phase III Randomized Study Of Adjuvant Hormonal Therapy With And Without Docetaxel And Estramustine In Patients With Advanced Prostate Cancer Or With A High Risk Of Relapse
Essai Clinique (Sanofi)   17 janvier 2023
EVIDENS: Lung Cancer Patients Treated With Nivolumab: A Longitudinal, Prospective, Observational, Multicentric Study
Essai Clinique (BMS)   18 mai 2022
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer: Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers
Essai Clinique (Unicancer)   19 février 2021
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study.
Oncoimmunology   12 avril 2020
Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.
World journal of gastroenterology   14 février 2020
Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma.
JAMA network open   05 avril 2019